CAESARS ENTERTAINMENT INC (CZR) Fundamental Analysis & Valuation

NASDAQ:CZR • US12769G1004

Current stock price

26.88 USD
+0.44 (+1.66%)
At close:
26.9753 USD
+0.1 (+0.35%)
After Hours:

This CZR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CZR Profitability Analysis

1.1 Basic Checks

  • In the past year CZR has reported negative net income.
  • CZR had a positive operating cash flow in the past year.
  • In the past 5 years CZR reported 4 times negative net income.
  • CZR had a positive operating cash flow in each of the past 5 years.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • CZR has a worse Return On Assets (-1.59%) than 71.43% of its industry peers.
  • The Return On Equity of CZR (-14.33%) is worse than 60.32% of its industry peers.
  • CZR has a Return On Invested Capital (5.59%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for CZR is below the industry average of 10.56%.
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROIC 5.59%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • CZR has a better Operating Margin (18.09%) than 78.57% of its industry peers.
  • CZR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 47.20%, CZR is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • CZR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.09%
PM (TTM) N/A
GM 47.2%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CZR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CZR is still creating some value.
  • Compared to 1 year ago, CZR has less shares outstanding
  • The number of shares outstanding for CZR has been reduced compared to 5 years ago.
  • The debt/assets ratio for CZR is higher compared to a year ago.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that CZR is in the distress zone and has some risk of bankruptcy.
  • CZR has a worse Altman-Z score (0.53) than 75.40% of its industry peers.
  • CZR has a debt to FCF ratio of 50.47. This is a negative value and a sign of low solvency as CZR would need 50.47 years to pay back of all of its debts.
  • The Debt to FCF ratio of CZR (50.47) is worse than 61.11% of its industry peers.
  • A Debt/Equity ratio of 7.07 is on the high side and indicates that CZR has dependencies on debt financing.
  • CZR has a worse Debt to Equity ratio (7.07) than 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Altman-Z 0.53
ROIC/WACC1.12
WACC4.97%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.80 indicates that CZR may have some problems paying its short term obligations.
  • CZR has a Current ratio of 0.80. This is in the lower half of the industry: CZR underperforms 61.11% of its industry peers.
  • CZR has a Quick Ratio of 0.80. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CZR has a Quick ratio (0.78) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.78
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CZR Growth Analysis

3.1 Past

  • CZR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -228.38%.
  • CZR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
  • The Revenue has been growing by 25.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%

3.2 Future

  • Based on estimates for the next years, CZR will show a very strong growth in Earnings Per Share. The EPS will grow by 30.63% on average per year.
  • The Revenue is expected to grow by 3.10% on average over the next years.
EPS Next Y96.76%
EPS Next 2Y50.53%
EPS Next 3Y35.77%
EPS Next 5Y30.63%
Revenue Next Year2.82%
Revenue Next 2Y2.63%
Revenue Next 3Y2.51%
Revenue Next 5Y3.1%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

3

4. CZR Valuation Analysis

4.1 Price/Earnings Ratio

  • CZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CZR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CZR is valued a bit cheaper than 79.37% of the companies in the same industry.
  • CZR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CZR is cheaper than 89.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.1
EV/EBITDA 8.4
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CZR's earnings are expected to grow with 35.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.53%
EPS Next 3Y35.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CZR Dividend Analysis

5.1 Amount

  • CZR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CZR Fundamentals: All Metrics, Ratios and Statistics

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (4/10/2026, 8:15:32 PM)

After market: 26.9753 +0.1 (+0.35%)

26.88

+0.44 (+1.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners111.94%
Inst Owner Change0%
Ins Owners1.04%
Ins Owner Change3.6%
Market Cap5.47B
Revenue(TTM)11.49B
Net Income(TTM)-502.00M
Analysts77.5
Price Target32.55 (21.09%)
Short Float %13.53%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-513.02%
Min EPS beat(2)-639.28%
Max EPS beat(2)-386.76%
EPS beat(4)0
Avg EPS beat(4)-533.78%
Min EPS beat(4)-925.61%
Max EPS beat(4)-183.48%
EPS beat(8)1
Avg EPS beat(8)-434.23%
EPS beat(12)2
Avg EPS beat(12)-1183.03%
EPS beat(16)3
Avg EPS beat(16)-932.06%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)-0.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)5
Avg Revenue beat(16)-0.89%
PT rev (1m)-5.34%
PT rev (3m)-9.31%
EPS NQ rev (1m)6.72%
EPS NQ rev (3m)-75.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-127.9%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-1.07%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF 11.1
P/OCF 4.2
P/B 1.56
P/tB N/A
EV/EBITDA 8.4
EPS(TTM)-2.43
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)2.42
FCFY9.01%
OCF(TTM)6.4
OCFY23.8%
SpS56.44
BVpS17.22
TBVpS-53.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.59%
ROE -14.33%
ROCE 7.07%
ROIC 5.59%
ROICexc 5.76%
ROICexgc 11.67%
OM 18.09%
PM (TTM) N/A
GM 47.2%
FCFM 4.29%
ROA(3y)-0.03%
ROA(5y)-1.09%
ROE(3y)-1.25%
ROE(5y)-10.14%
ROIC(3y)6.03%
ROIC(5y)5.39%
ROICexc(3y)6.22%
ROICexc(5y)5.57%
ROICexgc(3y)12.71%
ROICexgc(5y)11.43%
ROCE(3y)7.63%
ROCE(5y)6.83%
ROICexgc growth 3Y3.82%
ROICexgc growth 5Y91.84%
ROICexc growth 3Y5.32%
ROICexc growth 5Y87.13%
OM growth 3Y1.7%
OM growth 5Y45.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y1.53%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 7.07
Debt/FCF 50.47
Debt/EBITDA 7.09
Cap/Depr 57.09%
Cap/Sales 7.04%
Interest Coverage 2.56
Cash Conversion 37.25%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.78
Altman-Z 0.53
F-Score5
WACC4.97%
ROIC/WACC1.12
Cap/Depr(3y)86.24%
Cap/Depr(5y)82.51%
Cap/Sales(3y)9.98%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-228.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2560%
EPS Next Y96.76%
EPS Next 2Y50.53%
EPS Next 3Y35.77%
EPS Next 5Y30.63%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y2.01%
Revenue growth 5Y25.92%
Sales Q2Q%4.18%
Revenue Next Year2.82%
Revenue Next 2Y2.63%
Revenue Next 3Y2.51%
Revenue Next 5Y3.1%
EBIT growth 1Y-8.66%
EBIT growth 3Y3.74%
EBIT growth 5Y82.73%
EBIT Next Year82.3%
EBIT Next 3Y24.69%
EBIT Next 5Y17.36%
FCF growth 1Y308.9%
FCF growth 3Y245.06%
FCF growth 5YN/A
OCF growth 1Y21.12%
OCF growth 3Y10.12%
OCF growth 5YN/A

CAESARS ENTERTAINMENT INC / CZR Fundamental Analysis FAQ

What is the fundamental rating for CZR stock?

ChartMill assigns a fundamental rating of 2 / 10 to CZR.


Can you provide the valuation status for CAESARS ENTERTAINMENT INC?

ChartMill assigns a valuation rating of 3 / 10 to CAESARS ENTERTAINMENT INC (CZR). This can be considered as Overvalued.


How profitable is CAESARS ENTERTAINMENT INC (CZR) stock?

CAESARS ENTERTAINMENT INC (CZR) has a profitability rating of 3 / 10.